Aspo’s EUR 9.2m comparable EBITA fell some EUR 1m short of the estimates; in our view this was due to ESL as Telko and Leipurin delivered EBITA in line or slightly higher than estimates. Aspo retains its FY’25 guidance, however comments regarding ESL’s H2 outlook seem a bit cautious.

Evli

Läs mer på Evli Research

Ämnen i artikeln

Aspo

Senast

5,68

1 dag %

−0,70%

1 dag

1 mån

1 år

Marknadsöversikt

1 DAG %

Senast

1 mån